Jisong Cui

2.8k total citations
27 papers, 2.2k citations indexed

About

Jisong Cui is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Jisong Cui has authored 27 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Molecular Biology and 9 papers in Genetics. Recurrent topics in Jisong Cui's work include Drug Transport and Resistance Mechanisms (8 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (7 papers) and Hypothalamic control of reproductive hormones (6 papers). Jisong Cui is often cited by papers focused on Drug Transport and Resistance Mechanisms (8 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (7 papers) and Hypothalamic control of reproductive hormones (6 papers). Jisong Cui collaborates with scholars based in United States, Spain and Russia. Jisong Cui's co-authors include Li Huang, Samuel D. Wright, Annie Zhao, Jinghua Yu, David Ginsburg, Fernando Peláez, Anjali Purkayastha, Thomas L. Saunders, K. Sue O’Shea and Nuria de Pedro and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Jisong Cui

27 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jisong Cui United States 21 751 561 559 481 303 27 2.2k
Annemieke Kuil Netherlands 19 1.4k 1.8× 314 0.6× 617 1.1× 216 0.4× 157 0.5× 23 2.4k
Barbara Gross France 18 279 0.4× 409 0.7× 1.1k 1.9× 427 0.9× 483 1.6× 31 2.3k
Eitaro Taniguchi Japan 27 422 0.6× 420 0.7× 832 1.5× 122 0.3× 1.1k 3.7× 66 2.9k
M Hanano Japan 23 571 0.8× 208 0.4× 300 0.5× 381 0.8× 146 0.5× 68 1.6k
Yasuhide Ikenaka Japan 27 370 0.5× 330 0.6× 896 1.6× 118 0.2× 1.1k 3.7× 55 2.9k
Sinéad Toomey Ireland 19 494 0.7× 234 0.4× 714 1.3× 301 0.6× 236 0.8× 66 2.0k
Junichi Yoshii Japan 25 361 0.5× 301 0.5× 915 1.6× 116 0.2× 1.0k 3.3× 42 2.7k
Shigang Xiong United States 24 241 0.3× 476 0.8× 1.1k 2.0× 306 0.6× 1.3k 4.3× 37 2.9k
J. Kar Kruijt Netherlands 30 382 0.5× 1.0k 1.8× 1.1k 1.9× 167 0.3× 561 1.9× 53 2.7k
Lita A. Freeman United States 35 585 0.8× 1.5k 2.6× 1.3k 2.4× 114 0.2× 370 1.2× 73 3.2k

Countries citing papers authored by Jisong Cui

Since Specialization
Citations

This map shows the geographic impact of Jisong Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jisong Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jisong Cui more than expected).

Fields of papers citing papers by Jisong Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jisong Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jisong Cui. The network helps show where Jisong Cui may publish in the future.

Co-authorship network of co-authors of Jisong Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Jisong Cui. A scholar is included among the top collaborators of Jisong Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jisong Cui. Jisong Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Bin, Renbin Zhao, Richard Liu, et al.. (2020). Abstract CT132: Orelabrutinib, a potent and selective Bruton's tyrosine kinase inhibitor with superior safety profile and excellent PK/PD properties. Cancer Research. 80(16_Supplement). CT132–CT132. 21 indexed citations
2.
Chu, Lin, Linda Chang, Lawrence F. Colwell, et al.. (2012). Evaluation of endo- and exo-aryl-substitutions and central scaffold modifications on diphenyl substituted alkanes as 5-lipoxygenase activating protein inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(12). 4133–4138. 21 indexed citations
3.
Zhao, Lei, Michael Moos, Rolf Gräbner, et al.. (2004). The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm. Nature Medicine. 10(9). 966–973. 292 indexed citations
4.
Jiang, Jinlong, Robert J. DeVita, Mark T. Goulet, et al.. (2004). Syntheses and structure–activity relationship studies of piperidine-substituted quinolones as nonpeptide gonadotropin releasing hormone antagonists. Bioorganic & Medicinal Chemistry Letters. 14(7). 1795–1798. 18 indexed citations
5.
Zhao, Annie, et al.. (2004). Polyunsaturated Fatty Acids Are FXR Ligands and Differentially Regulate Expression of FXR Targets. DNA and Cell Biology. 23(8). 519–526. 103 indexed citations
6.
Zhao, Annie, Jinghua Yu, Li Huang, et al.. (2004). The Farnesoid X Receptor Controls Gene Expression in a Ligand- and Promoter-selective Fashion. Journal of Biological Chemistry. 279(10). 8856–8861. 171 indexed citations
7.
DeVita, Robert J., Jinlong Jiang, Jonathan R. Young, et al.. (2004). Identification of neutral 4-O-alkyl quinolone nonpeptide GnRH receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 14(22). 5599–5603. 6 indexed citations
8.
Wassif, Christopher A., Jinghua Yu, Jisong Cui, Forbes D. Porter, & Norman B. Javitt. (2003). 27-Hydroxylation of 7- and 8-dehydrocholesterol in Smith–Lemli–Opitz syndrome: a novel metabolic pathway. Steroids. 68(6). 497–502. 41 indexed citations
9.
Huang, Li, Annie Zhao, Theresa Zhang, et al.. (2003). Farnesoid X Receptor Activates Transcription of the Phospholipid Pump MDR3. Journal of Biological Chemistry. 278(51). 51085–51090. 175 indexed citations
10.
Cui, Jisong, Li Huang, Annie Zhao, et al.. (2003). Guggulsterone Is a Farnesoid X Receptor Antagonist in Coactivator Association Assays but Acts to Enhance Transcription of Bile Salt Export Pump. Journal of Biological Chemistry. 278(12). 10214–10220. 200 indexed citations
11.
Zhao, Annie, Li Huang, Jinghua Yu, et al.. (2003). Human Kininogen Gene Is Transactivated by the Farnesoid X Receptor. Journal of Biological Chemistry. 278(31). 28765–28770. 33 indexed citations
12.
Young, Jonathan R., Thomas F. Walsh, Matthew J. Wyvratt, et al.. (2002). 2-Arylindoles as gonadotropin releasing hormone (GnRH) antagonists: optimization of the tryptamine side chain. Bioorganic & Medicinal Chemistry Letters. 12(5). 827–832. 32 indexed citations
13.
Bugianesi, Robert L., Mitree M. Ponpipom, Yi Yang, et al.. (2002). Modification of the pyridine moiety of non-peptidyl indole GnRH receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 12(22). 3329–3332. 12 indexed citations
14.
Yu, Jinghua, Li Huang, Annie Zhao, et al.. (2002). Lithocholic Acid Decreases Expression of Bile Salt Export Pump through Farnesoid X Receptor Antagonist Activity. Journal of Biological Chemistry. 277(35). 31441–31447. 153 indexed citations
15.
Cui, Jisong, Thomas S. Heard, Jinghua Yu, et al.. (2002). The Amino Acid Residues Asparagine 354 and Isoleucine 372 of Human Farnesoid X Receptor Confer the Receptor with High Sensitivity to Chenodeoxycholate. Journal of Biological Chemistry. 277(29). 25963–25969. 33 indexed citations
16.
Ashton, Wallace T., G. R. KIECZYKOWSKI, Joel B. Yudkovitz, et al.. (2001). Orally bioavailable, indole-based nonpeptide GnRH receptor antagonists with high potency and functional activity. Bioorganic & Medicinal Chemistry Letters. 11(19). 2597–2602. 42 indexed citations
17.
Cui, Jisong, et al.. (2000). Prothrombotic phenotype of protein Z deficiency. Proceedings of the National Academy of Sciences. 97(12). 6734–6738. 115 indexed citations
18.
Cui, Jisong, Daniel T. Eitzman, Randal J. Westrick, et al.. (2000). Spontaneous thrombosis in mice carrying the factor V Leiden mutation. Blood. 96(13). 4222–4226. 114 indexed citations
19.
Cui, Jisong, Richard L. Wahl, Tingliang Shen, et al.. (1999). Bone marrow cell trafficking following intravenous administration. British Journal of Haematology. 107(4). 895–902. 74 indexed citations
20.
Cui, Jisong, K. Sue O’Shea, Anjali Purkayastha, Thomas L. Saunders, & David Ginsburg. (1996). Fatal haemorrhage and incomplete block to embryogenesis in mice lacking coagulation factor V. Nature. 384(6604). 66–68. 201 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Annemieke Kuil Breakdown of academic impact, for papers by Barbara Gross Breakdown of academic impact, for papers by Eitaro Taniguchi Breakdown of academic impact, for papers by M Hanano Breakdown of academic impact, for papers by Yasuhide Ikenaka Breakdown of academic impact, for papers by Sinéad Toomey Breakdown of academic impact, for papers by Junichi Yoshii Breakdown of academic impact, for papers by Shigang Xiong Breakdown of academic impact, for papers by J. Kar Kruijt Breakdown of academic impact, for papers by Lita A. Freeman
Rankless by CCL
2026